Cargando…
Development of Streptomyces sp. FR-008 as an emerging chassis()
Microbial-derived natural products are important in both the pharmaceutical industry and academic research. As the metabolic potential of original producer especially Streptomyces is often limited by slow growth rate, complicated cultivation profile, and unfeasible genetic manipulation, so exploring...
Autores principales: | Liu, Qian, Xiao, Liping, Zhou, Yuanjie, Deng, Kunhua, Tan, Gaoyi, Han, Yichao, Liu, Xinhua, Deng, Zixin, Liu, Tiangang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640794/ https://www.ncbi.nlm.nih.gov/pubmed/29062944 http://dx.doi.org/10.1016/j.synbio.2016.07.002 |
Ejemplares similares
-
Systematic mining of fungal chimeric terpene synthases using an efficient precursor-providing yeast chassis
por: Chen, Rong, et al.
Publicado: (2021) -
Streptomyces as Microbial Chassis for Heterologous Protein Expression
por: Hwang, Soonkyu, et al.
Publicado: (2021) -
Identification of Mur34 as the Novel Negative Regulator Responsible for the Biosynthesis of Muraymycin in Streptomyces sp. NRRL30471
por: Xu, Dongmei, et al.
Publicado: (2013) -
Building Streptomyces albus as a chassis for synthesis of bacterial terpenoids
por: Hu, Yi Ling, et al.
Publicado: (2023) -
Genome mining of astaxanthin biosynthetic genes from Sphingomonas sp. ATCC 55669 for heterologous overproduction in Escherichia coli
por: Ma, Tian, et al.
Publicado: (2015)